Providing adolescent-friendly hpv education

Nurse Practitioner

Volumn 36, Issue 11, 2011, Pages 35-40

  Daley, Alison Moriarty ^a  

^a YALE UNIVERSITY SCHOOL OF NURSING   (United States)

Author keywords

Adolescent vaccination; HPV education; Human papillomavirus; Sexually transmitted infection

Indexed keywords

WART VIRUS VACCINE;

ADOLESCENT; ADULT; ARTICLE; CHILD; FEMALE; HUMAN; MALE; NURSE PATIENT RELATIONSHIP; NURSE PRACTITIONER; PAPILLOMAVIRUS INFECTION; PATIENT EDUCATION; RISK ASSESSMENT; UNITED STATES; VACCINATION;

ADOLESCENT; CHILD; FEMALE; HUMANS; MALE; NURSE PRACTITIONERS; NURSE-PATIENT RELATIONS; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; PATIENT EDUCATION AS TOPIC; RISK ASSESSMENT; UNITED STATES; VACCINATION; YOUNG ADULT;

EID: 84857403986     PISSN: 03611817     EISSN: 15388662     Source Type: Journal    
DOI: 10.1097/01.NPR.0000406486.97876.1d     Document Type: Article

References (37)

1. American Academy of Pediatrics Committee on Infectious Diseases. Prevention of human papillomavirus infection: provisional recommendations for girls and womens with quadrivalent human papillomavirus vaccine. Pediatrics. 2007;120(3):666-668.
2. American Cancer Society. Detailed Guide: Cervical Cancer.
3. Centers for Disease Control and Prevention. HPV.
4. Maggino T, Casadei D, Panontin E, et al. Impact of an HPV diagnosis on the quality of life in young women. Gynecol Oncol. 2007;107(suppl 1):S175-S179.
5. McKee D, Fletcher J. Primary care for urban adolescent girls from ethnically diverse populations: foregone care and access to confidential care. J Health Care Poor Underserved. 2006;17(4):759-774.
6. Ford CA, Bearman PS, Moody J. Foregone health care among adolescents. JAMA. 1999;282(23):2227-2234.
7. Ginsberg KR, Forke CM, Cnaan A, Slap G. Important health provider characteristics: the perspective of urban ninth graders. J Dev Behav Pediatr. 2002;23(4):237-243.
8. Ginsberg KR, Menapace AS, Slap GB. Factors affecting the decision to seek health care: the voice of adolescents. Pediatrics. 1997;100(6):922-930.
9. Fox HB, Yurkiewicz SM, Philliber SG, McManus MA. Adolescents' Experiences and Views on Health Care. Washington, DC: The National Alliance to Advance Adolescent Health, 2010.
10. Sadler LS, Daley AM. A model of teen-friendly care for young women with negative pregnancy test results. Nurs Clin North Am. 2002;37(3):523-535.
11. Sussman AL, Helitzer D, Sanders M, Urquieta B, Salvador M, Ndiaye K. HPV and cervical cancer prevention counseling for younger adolescents: ismplications for primary care. Ann Fam Med. 2007;5(4):298-304.
12. McCave EL. Influential factors in HPV vaccination uptake among providers in four states. J Community Health. 2010;35(6):645-652.
13. Centers for Disease Control and Prevention (CDC). National, state, and local area vaccination coverage among adolescents aged 13-17 years—United States, 2009. MMWR Morb Mortal Wkly Rep. 2010;59(32):1018-1023.
14. Reiter PL, McRee AL, Gottlieb SL, Brewer NT. HPV vaccine for adolescent males: acceptiability to post-vaccine licensure. Vaccine. 2010;28(38):6292-6297.
15. Kahn JA, Ding L, Huang B, Zimet GD, Rosenthal, SL, Frazier AL. Mother's intention for daughters and themselves to receive the human papillomavirus vaccine: a national study of nurses. Pediatrics. 2009;123(6):1439-1445.
16. Davis K, Dickman ED, Ferris D, Dias JK. Human papillomonavirus vaccine acceptability among parents of 10- to15-year-old adolescents. J Low Genit Tract Dis. 2004;8(3):188-194.
17. Centers for Disease Control and Prevention (CDC). FDA licensure of bivalent Human Papillomavirus vaccine (HPV2, Cervarix) for use in females and updated vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep. 2010;59(20):626-629
18. Winer RL, Lee SK, Hughes JP, Adams DE, Kivat NB, Koutsky LA. Genital human papillomavirus infection: incidence and risk factors in a cohort of female university students. Am J Epidemiol. 2003;157(3):218-226.
19. Forhan SE, Gottlieb SL, Sternberg MR, et al. Prevalance of sexually transmitted infections among female adolescents aged 14 to 19 in the United States. Pediatrics. 2009;124(6):1505-1512.
20. Nielson CM, Flores R, Harris RB, et al. Human papillomaviris prevalence and type distribution in male anogenital sites and semen. Cancer Epidemiol Biomarkers Prev. 2007;16(6):1107-1114.
21. Dunne EF, Unger ER, Sternberg M, et al. Prevalence of HPV infection among females in the United States. JAMA. 2007;297(8):813-819.
22. Miller MM, Wilson JM, Waldrop J. Current acceptance of HPV vaccines. Nurse Pract. 2008;33(4):18-22.
23. McRee AL, Reiter PL, Gottlieb SL, Brewer NT. Mother-daughter comunication about HPV vaccine. J Adolesc Health. 2011;48(3):314-317.
24. Rubin SE, McKee MD, Campos G, O'Sullivan LF. Delivery of confidential care to adolescent males. J Am Board Fam Med, 2010;23(6):728-735.
25. English A, Ford CA. More evidence supports the need to protect confidentiality in adolescent health care. J Adolesc Health. 2007;40(3):199-200.
26. American Cancer Society. Cancer facts and figures 2006 .
27. American College of Obstetrics and Gynecology. First cervical cancer screening delayed until age 21: Less frequent Pap tests recommended.
28. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD. Natural history of cervicovaginal papillomavirus in young women. N Engl J Med. 1998;338(7):423-428.
29. Maggino T, Casadel D, Panontin E, et al. Impact of an HPV diagnosis on the quality of life in young women. Gynecol Oncol. 2007;107(suppl 1):S175-S179.
30. McNeely, C, Shew, ML, Beuthring, T, Sieving, R, Miller, BC, Blum, R. Mother's influence on timing of first sex among 14-and 15-year-olds. Journal of Adolescent Health. 2002,31:256-265. Oncology. 2007;107:S175-S170.
31. Markowitz, LE, Dunne, EF, Saraiya, M, Lawson, Chesson, HW, Unger, ER. Quadrivalent human papillomavirus vaccine: recommendation of the Advisory Committee on Immunization Practices (ACIP). MMWR, 2007, 56(RR02); 1-24.
32. Centers for Disease Control and Prevention. FDA licensure of quadravalent human papillomavirus vaccine (HPV4, Gardasil) for use in males and guidance from the Advisory Committee on Immunization Practices (ACIP). 2010, MMWR. 59(20);630-632.
33. U.S. Food and Drug Administration. December 22, 2010 approval letter-Gardasil. Rockville, MD: U.S. Department of Health and Human Services.
34. Centers for Disease Control and Prevention. Advisory Committee on Immunization Practices Vaccines For Children Program: Vaccines to prevent human papillomavirus. October 21, 2009. Resolution No. 010/09-1, 1-3.
35. Rand CM, Shone LP, Albertin C, Auinger P, Klein JD, Szilagyi PG. National health care visit patterns of adolescents. Arch Pediatr Adolesc Med. 2007;161(3):252-259.
36. Marcell AK, Klein JD, Fischer I, Allen MJ, Kokotailo PK. Male adolescents use of health care services: where are the boys? J Adolesc Health. 2002;30(1):35-43.
37. Broder KR, Cohn AC, Schwartz B, et al. Adolescent immunizations and other clinical preventative services: a needle and a hook? Pediatrics. 2008;121(suppl 1):S25-S34.